Northern Trust’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.7M Buy
899,146
+70,445
+9% +$1.57M ﹤0.01% 1691
2025
Q4
$17.8M Buy
828,701
+122,186
+17% +$2.14M ﹤0.01% 1745
2025
Q3
$8.27M Buy
706,515
+14,958
+2% +$149K ﹤0.01% 2222
2025
Q2
$6.43M Sell
691,557
-6,844
-1% -$56.1K ﹤0.01% 2323
2025
Q1
$4.7M Buy
698,401
+181,910
+35% +$1.75M ﹤0.01% 2443
2024
Q4
$5.49M Buy
516,491
+43,146
+9% +$521K ﹤0.01% 2456
2024
Q3
$6.92M Buy
473,345
+303,096
+178% +$4.31M ﹤0.01% 2289
2024
Q2
$2.06M Buy
170,249
+34,761
+26% +$544K ﹤0.01% 2882
2024
Q1
$3.34M Buy
135,488
+35,260
+35% +$716K ﹤0.01% 2712
2023
Q4
$1.07M Buy
100,228
+83,763
+509% +$696K ﹤0.01% 3293
2023
Q3
$137K Sell
16,465
-245
-1% -$1.8K ﹤0.01% 3930
2023
Q2
$132K Sell
16,710
-88
-0.5% -$481 ﹤0.01% 3962
2023
Q1
$83.8K Hold
16,798
﹤0.01% 4120
2022
Q4
$37.1K Hold
16,798
﹤0.01% 4356
2022
Q3
$75K Hold
16,798
﹤0.01% 4209
2022
Q2
$54K Hold
16,798
﹤0.01% 4381
2022
Q1
$95K Hold
16,798
﹤0.01% 4355
2021
Q4
$218K Hold
16,798
﹤0.01% 4170
2021
Q3
$409K Buy
+16,798
New +$293K ﹤0.01% 3845
2021
Q2
Sell
-27,114
Closed -$918K 4611
2021
Q1
$918K Buy
27,114
+1,827
+7% +$45.4K ﹤0.01% 3618
2020
Q4
$245K Buy
+25,287
New +$295K ﹤0.01% 3920

Other funds holding IMNM

Northern Trust's IMNM Position: Q1 2026 in Review

Northern Trust increased its Immunome (IMNM) stake by 8.5% in Q1 2026, buying an estimated $1.57M and bringing the position to 899,146 shares worth $19.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1691.

Northern Trust first reported a position in IMNM in Q4 2020 and has held it in 21 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Northern Trust held 899,146 shares of Immunome worth $19.7M as of Q1 2026.
  • Northern Trust bought 70,445 Immunome shares in Q1 2026, an estimated $1.57M.
  • Immunome made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1691 holding.
  • Northern Trust first reported a position in Immunome in Q4 2020 and has held it in 21 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.